Tert-butyl 4-[4-[[2-(4-chlorophenyl)-6-methoxy-1-benzothiophen-3-yl]oxy]phenyl]piperazine-1-carboxylate
C30H31ClN2O4S — CID 169268417
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[4-[[2-(4-chlorophenyl)-6-methoxy-1-benzothiophen-3-yl]oxy]phenyl]piperazine-1-carboxylate
Tert-butyl 4-[4-[[2-(4-chlorophenyl)-6-methoxy-1-benzothiophen-3-yl]oxy]phenyl]piperazine-1-carboxylate (PubChem CID 169268417) has the molecular formula C30H31ClN2O4S and a molecular weight of 551.11 g/mol. Its IUPAC name is tert-butyl 4-[4-[[2-(4-chlorophenyl)-6-methoxy-1-benzothiophen-3-yl]oxy]phenyl]piperazine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-[4-[[2-(4-chlorophenyl)-6-methoxy-1-benzothiophen-3-yl]oxy]phenyl]piperazine-1-carboxylate |
|---|---|
| PubChem CID | 169268417 |
| Molecular Formula | C30H31ClN2O4S |
| Molecular Weight | 551.11 g/mol |
| Exact Mass | 550.17 |
| IUPAC Name | tert-butyl 4-[4-[[2-(4-chlorophenyl)-6-methoxy-1-benzothiophen-3-yl]oxy]phenyl]piperazine-1-carboxylate |
| SMILES | COc1ccc2c(Oc3ccc(N4CCN(C(=O)OC(C)(C)C)CC4)cc3)c(-c3ccc(Cl)cc3)sc2c1 |
| InChI | InChI=1S/C30H31ClN2O4S/c1-30(2,3)37-29(34)33-17-15-32(16-18-33)22-9-11-23(12-10-22)36-27-25-14-13-24(35-4)19-26(25)38-28(27)20-5-7-21(31)8-6-20/h5-14,19H,15-18H2,1-4H3 |
| InChIKey | UELRIMBMMDFZPV-UHFFFAOYSA-N |
| XLogP | 8.08 |
| TPSA | 51.24 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 551.11 |
| LogP ≤ 5 | 8.08 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169268417 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.